Vascular Biogenics Ltd. (VBL)

Healthcare 📍 Or Yehuda, Israel 👥 11-50 employees 📅 Founded 2000

VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer. The Company's lead oncology product candidate, VB-111, is a gene-based biologic that is initially being developed for recurrent glioblastoma, or rGBM, an ag

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Israel

Employees

11-50

Founded

2000

Cloud

Netlify

CDN

Netlify

Email

Microsoft 365

☁️ Cloud Infrastructure

Netlify Detected Cloud Provider

Detected via HTTP headers

Workspace	Microsoft 365
CDN	Netlify

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year on Netlify

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	Nuxt

Detected from Vascular Biogenics Ltd. (VBL)'s public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction